← Leaderboards
Xiangshu Xiao
Oregon Health & Science University
$6,932,744
Attributed
$7,819,306
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $922.6K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,819,306 · 5
By mechanism
R01$7,450,861 · 4
R21$368,445 · 1
Top collaborators
- Bingbing Li3 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Bingbing Li$3,260,367
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMalignant Breast NeoplasmCellsMolecularCancer CellSmall MoleculeNormal CellSeriesBindingToxic EffectStructure-Activity RelationshipChemoproteomicsPathway InteractionsBiochemicalProteinsIn VivoOverexpressionPhosphotransferasesBinding ProteinsNuclearTp53 GeneBaseLigand BindingDna Biosynthesis
Grant awards (24)
Small molecules targeting RuvBL complex for triple negative breast cancer$601,059
R01 · FY2025 · CA · contact PI
Small molecules targeting RuvBL complex for triple negative breast cancer$571,007
R01 · FY2024 · CA · contact PI
Small molecules targeting RuvBL complex for triple negative breast cancer$601,059
R01 · FY2023 · CA · contact PI
Synergistic Inhibitors of CREB-mediated Gene Transcription$321,506
R01 · FY2023 · GM · contact PI
Synergistic Inhibitors of CREB-mediated Gene Transcription$320,081
R01 · FY2022 · GM · contact PI
Chemical Modulators of Nuclear Lamins$120,594
R01 · FY2022 · CA · contact PI
Chemical Modulators of Nuclear Lamins$352,275
R01 · FY2021 · CA · contact PI
Chemical Modulators of Nuclear Lamins$113,971
R01 · FY2021 · CA · contact PI
Chemical Modulators of Nuclear Lamins$466,246
R01 · FY2020 · CA · contact PI
Targeting Hsp60 to Inhibit CREB-mediated Gene Transcription$323,400
R01 · FY2020 · GM · contact PI
Chemical Modulators of Nuclear Lamins$52,556
R01 · FY2020 · CA · contact PI
Chemical Modulators of Nuclear Lamins$341,706
R01 · FY2019 · CA · contact PI
Targeting Hsp60 to Inhibit CREB-mediated Gene Transcription$317,217
R01 · FY2019 · GM · contact PI
Chemical Modulators of Nuclear Lamins$352,275
R01 · FY2018 · CA · contact PI
Targeting Hsp60 to Inhibit CREB-mediated Gene Transcription$322,879
R01 · FY2018 · GM · contact PI
Targeting EWS-ATF1 in CCSST$167,475
R21 · FY2018 · CA · contact PI
Chemical Modulators of Nuclear Lamins$352,275
R01 · FY2017 · CA · contact PI
Targeting Hsp60 to Inhibit CREB-mediated Gene Transcription$325,056
R01 · FY2017 · GM · contact PI
Targeting EWS-ATF1 in CCSST$200,970
R21 · FY2017 · CA · contact PI
Chemical Inhibitors of CREB-mediated Gene Transcription$320,166
R01 · FY2014 · GM · contact PI
Chemical Inhibitors of CREB-mediated Gene Transcription$308,961
R01 · FY2013 · GM · contact PI
Chemical Inhibitors of CREB-mediated Gene Transcription$320,166
R01 · FY2012 · GM · contact PI
Chemical Inhibitors of CREB-mediated Gene Transcription$320,166
R01 · FY2011 · GM · contact PI
Chemical Inhibitors of CREB-mediated Gene Transcription$326,240
R01 · FY2010 · GM · contact PI